These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Center is an important indicator for choice of invasive therapy in polycystic liver disease. D'Agnolo HM, Kievit W, van Munster KN, van der Laan JJ, Nevens F, Drenth JP. Transpl Int; 2017 Jan; 30(1):76-82. PubMed ID: 27732751 [Abstract] [Full Text] [Related]
33. [Current opinions on the etiology and pathogenesis of autosomal dominant polycystic kidney disease (ADPKD). II. Factors other than genetic factors which have an influence on disease course and selected clinical problems]. Jasik P, Sułowicz W, Kraśniak A, Stompór T. Przegl Lek; 1998 Apr; 55(11):599-606. PubMed ID: 10216375 [Abstract] [Full Text] [Related]
36. Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease. Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH. Neth J Med; 2018 Jul; 76(5):226-234. PubMed ID: 30019678 [Abstract] [Full Text] [Related]
37. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. Abu-Wasel B, Walsh C, Keough V, Molinari M. World J Gastroenterol; 2013 Sep 21; 19(35):5775-86. PubMed ID: 24124322 [Abstract] [Full Text] [Related]
38. Intravascular embolization therapy in patients with enlarged polycystic liver. Hoshino J, Ubara Y, Suwabe T, Sumida K, Hayami N, Mise K, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Takei R, Takaichi K. Am J Kidney Dis; 2014 Jun 21; 63(6):937-44. PubMed ID: 24602778 [Abstract] [Full Text] [Related]
39. Advances in management of polycystic liver disease. Everson GT, Helmke SM, Doctor B. Expert Rev Gastroenterol Hepatol; 2008 Aug 21; 2(4):563-76. PubMed ID: 19072404 [Abstract] [Full Text] [Related]
40. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease. Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z. Am J Kidney Dis; 2010 May 21; 55(5):916-22. PubMed ID: 20189277 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]